EYEPOINT PHARMACEUTICALS INC (EYPT) Stock Analyst Earnings Estimates
NASDAQ:EYPT - Nasdaq - US30233G2093 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 41.4M 12.07% | 46.018M 11.15% | 43.273M -5.97% | 18M -58.40% | 13.016M -27.69% | 56.972M 337.71% | 274.89M 382.50% | 531.15M 93.22% | 803.54M 51.28% | 1.032B 28.43% | 1.133B 9.79% | |
| EBITDA YoY % growth | -76.49M -45.67% | -74.603M 2.47% | N/A 132.48% | 12.717M -47.52% | -16.562M -230.23% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -78.94M -42.80% | -75.067M 4.91% | -145.854M -94.30% | -193.481M -32.65% | -237.386M -22.69% | -193.137M 18.64% | -4.08M 97.89% | 195.98M 4,903.43% | 409.82M 109.11% | 590.8M 44.16% | 663.29M 12.27% | |
| Operating Margin | -190.68% | -163.13% | -337.06% | -1,074.90% | -1,823.80% | -339.00% | -1.48% | 36.90% | 51.00% | 57.25% | 58.54% | |
| EPS YoY % growth | -2.73 -35.15% | -1.83 32.97% | -2.31 -26.23% | -2.64 -14.07% | -2.96 -12.26% | -2.18 26.21% | 0.77 135.33% | 3.25 321.16% | 5.61 72.86% | 8.61 53.39% | 9.88 14.78% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.59 -6.64% | -0.60 -3.98% | -0.65 -21.01% | -0.70 -8.60% |
| Revenue Q2Q % growth | 7.193M -38.44% | 6.588M -30.48% | 3.901M -62.93% | 2.497M -78.46% |
| EBITDA Q2Q % growth | -44.933M -36.09% | -45.613M -34.63% | -44.952M -41.92% | N/A |
| EBIT Q2Q % growth | -44.032M -32.15% | -45.318M -31.18% | -48.001M -46.58% | -49.992M -10.51% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.64 -93.94% | -0.51 | -0.13 | -25.16% |
| Q3 2024 Q2Q % growth | -0.54 -63.64% | -0.57 | 0.03 | 4.90% |
| Q2 2024 Q2Q % growth | -0.58 4.92% | -0.54 | -0.04 | -8.31% |
| Q1 2024 Q2Q % growth | -0.55 1.79% | -0.42 | -0.13 | -29.62% |
| Q4 2023 Q2Q % growth | -0.33 71.55% | -0.50 | 0.17 | 33.44% |
| Q3 2023 Q2Q % growth | -0.33 32.65% | -0.52 | 0.19 | 36.92% |
| Q2 2023 Q2Q % growth | -0.61 -17.31% | 0.61 | -1.22 | -199.88% |
| Q1 2023 Q2Q % growth | -0.56 | -0.70 | 0.14 | 19.66% |
| Q4 2022 Q2Q % growth | -1.16 -96.61% | -0.62 | -0.54 | -86.44% |
| Q3 2022 Q2Q % growth | -0.49 15.52% | -0.71 | 0.22 | 30.98% |
| Q2 2022 Q2Q % growth | -0.52 -48.57% | -0.53 | 0.01 | 2.58% |
| Q1 2022 Q2Q % growth | -0.56 -12.00% | -0.59 | 0.03 | 5.01% |
| Q4 2021 Q2Q % growth | -0.59 41.00% | -0.55 | -0.04 | -8.12% |
| Q3 2021 Q2Q % growth | -0.58 -93.33% | -0.41 | -0.17 | -41.45% |
| Q2 2021 Q2Q % growth | -0.35 65.00% | -0.44 | 0.09 | 20.20% |
| Q1 2021 Q2Q % growth | -0.50 54.55% | -0.47 | -0.03 | -7.50% |
| Q4 2020 Q2Q % growth | -1.00 | -0.18 | -0.82 | -463.44% |
| Q3 2020 Q2Q % growth | -0.30 80.00% | -0.31 | 0.01 | 1.96% |
| Q2 2020 Q2Q % growth | -1.00 9.09% | -1.07 | 0.07 | 6.63% |
| Q1 2020 Q2Q % growth | -1.10 31.25% | -0.97 | -0.13 | -12.92% |
| Q4 2019 Q2Q % growth | -1.00 | -1.19 | 0.19 | 15.85% |
| Q3 2019 Q2Q % growth | -1.50 | -1.40 | -0.10 | -6.95% |
| Q2 2019 Q2Q % growth | -1.10 | -1.22 | 0.12 | 10.13% |
| Q1 2019 Q2Q % growth | -1.60 | -1.39 | -0.21 | -14.77% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 11.59M -17.38% | 11.314M | 276K | 2.44% |
| Q3 2024 Q2Q % growth | 10.524M -30.77% | 10.276M | 248K | 2.41% |
| Q2 2024 Q2Q % growth | 9.477M 4.09% | 9.785M | -308K | -3.15% |
| Q1 2024 Q2Q % growth | 11.684M 52.08% | 10.185M | 1.499M | 14.72% |
| Q4 2023 Q2Q % growth | 14.028M 33.22% | 9.082M | 4.946M | 54.46% |
| Q3 2023 Q2Q % growth | 15.202M 51.87% | 7.676M | 7.526M | 98.05% |
| Q2 2023 Q2Q % growth | 9.105M -21.31% | 52.955M | -43.85M | -82.81% |
| Q1 2023 Q2Q % growth | 7.683M -17.30% | 7.577M | 106K | 1.40% |
| Q4 2022 Q2Q % growth | 10.53M -8.75% | 10.609M | -79K | -0.74% |
| Q3 2022 Q2Q % growth | 10.01M 10.49% | 10.857M | -847K | -7.80% |
| Q2 2022 Q2Q % growth | 11.57M 28.41% | 11.086M | 484K | 4.37% |
| Q1 2022 Q2Q % growth | 9.29M 26.91% | 10.085M | -795K | -7.88% |
| Q4 2021 Q2Q % growth | 11.54M 61.85% | 9.998M | 1.542M | 15.42% |
| Q3 2021 Q2Q % growth | 9.06M -42.29% | 10.039M | -979K | -9.75% |
| Q2 2021 Q2Q % growth | 9.01M 118.69% | 9.317M | -307K | -3.30% |
| Q1 2021 Q2Q % growth | 7.32M -2.27% | 8.085M | -765K | -9.46% |
| Q4 2020 Q2Q % growth | 7.13M -17.38% | 20.851M | -13.721M | -65.80% |
| Q3 2020 Q2Q % growth | 15.7M 525.50% | 13.579M | 2.121M | 15.62% |
| Q2 2020 Q2Q % growth | 4.12M -42.86% | 3.802M | 318K | 8.36% |
| Q1 2020 Q2Q % growth | 7.49M 272.64% | 7.399M | 91K | 1.23% |
| Q4 2019 Q2Q % growth | 8.63M | 7.319M | 1.311M | 17.91% |
| Q3 2019 Q2Q % growth | 2.51M | 4.013M | -1.503M | -37.45% |
| Q2 2019 Q2Q % growth | 7.21M | 6.826M | 384K | 5.63% |
| Q1 2019 Q2Q % growth | 2.01M | 3.457M | -1.447M | -41.86% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.51% | 4.51% | 0.5% | 3.21% |
| Revenue | -0.67% | 4.13% | -2.42% | 14.5% |